A B S T R A C T The Mediterranean storm track constitutes a well-defined branch of the North Hemisphere storm track and is characterised by small but intense features and frequent cyclogenesis. The goal of this study is to assess the level of consensus among cyclone detection and tracking methods (CDTMs), to identify robust features and to explore sources of disagreement. A set of 14 CDTMs has been applied for computing the climatology of cyclones crossing the Mediterranean region using the ERA-Interim dataset for the period 1979Á2008 as common testbed. Results show large differences in actual cyclone numbers identified by different methods, but a good level of consensus on the interpretation of results regarding location, annual cycle and trends of cyclone tracks. Cyclogenesis areas such as the north-western Mediterranean, North Africa, north shore of the Levantine basin, as well as the seasonality of their maxima are robust features on which methods show a substantial agreement. Differences among methods are greatly reduced if cyclone numbers are transformed to a dimensionless index, which, in spite of disagreement on mean values and interannual variances of cyclone numbers, reveals a consensus on variability, sign and significance of trends. Further, excluding 'weak' and 'slow' cyclones from the computation of cyclone statistics improves the agreement among CDTMs. Results show significant negative trends of cyclone frequency in spring and positive trends in summer, whose contrasting effects compensate each other at annual scale, so that there is no significant long-term trend in total cyclone numbers in the Mediterranean basin in the 1979Á2008 period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.